FindMyKOL

Adam Berlinberg, MD

Basic profile

University of Colorado Anschutz

ORCID↗NPI↗
✓ Itemized record
Region🇺🇸 Denver, CO · West · United StatesSpecialtyRheumatologyFocusGut microbiota and health+4
Active KOLFindMyKOL type: RegionalLatest publication2023Online presenceverified 2026Payments2021 onwardNIH fundingNot yet indexedWhy? →

Adam Berlinberg is a Gut microbiota and health physician affiliated with University of Colorado Anschutz. OpenAlex indexes 18 publications with 435 citations (h-index 9).

Overview

Updated 27 Oct 2026

Adam Berlinberg, MD, is affiliated with Denver Arthritis Clinic. The public record shows 18 publications with 438 citations (h-index 9), centered on Gut microbiota and health, Rheumatoid Arthritis Research and Therapies, Spondyloarthritis Studies and Treatments. It also documents industry payments reported by 37 companies.

  • Top research focus: Gut microbiota and health
  • Open Payments reporting from 37 companies

Generated from the cited public record · current as of 27 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Rheumatoid ArthritisAnkylosing Spondylitis / SpAIBD (Crohn's / UC)

Research focus

OpenAlex concept fingerprint
Gut microbiota and healthRheumatoid Arthritis Research and TherapiesSpondyloarthritis Studies and TreatmentsInflammatory Bowel DiseaseTryptophan and brain disorders

Drugs & molecules

across trials, industry payments and publications
Cosentyxgeneric · SecukinumabClinical trials—Industry payments11Publications1Taltzgeneric · IxekizumabClinical trials—Industry payments4Publications1Tremfyageneric · GuselkumabClinical trials—Industry payments3Publications1Stelarageneric · UstekinumabClinical trials—Industry payments1Publications1Krystexxageneric · PegloticaseClinical trials—Industry payments112Publications—Benlystageneric · BelimumabClinical trials—Industry payments47Publications—Rinvoqgeneric · UpadacitinibClinical trials—Industry payments27Publications—Upliznageneric · InebilizumabClinical trials—Industry payments24Publications—Bimzelxgeneric · BimekizumabClinical trials—Industry payments20Publications—Xeljanzgeneric · TofacitinibClinical trials—Industry payments20Publications—Acthargeneric · CorticotropinClinical trials—Industry payments17Publications—Saphnelogeneric · AnifrolumabClinical trials—Industry payments16Publications—

Works with

trial sponsors and companies reporting payments
Amgen Inc.Clinical trials—Industry payments143GlaxoSmithKline, LLC.Clinical trials—Industry payments50Abbvie Inc.Clinical trials—Industry payments39Pfizer Inc.Clinical trials—Industry payments29UCB, Inc.Clinical trials—Industry payments28Horizon Therapeutics plcClinical trials—Industry payments27AstraZeneca Pharmaceuticals LPClinical trials—Industry payments17Novartis Pharmaceuticals CorporationClinical trials—Industry payments13Sandoz Inc.Clinical trials—Industry payments10Mallinckrodt Hospital Products Inc.Clinical trials—Industry payments9ANI Pharmaceuticals, Inc.Clinical trials—Industry payments7E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments7Organon LLCClinical trials—Industry payments6Radius Health, Inc.Clinical trials—Industry payments6Sobi, IncClinical trials—Industry payments6Genzyme CorporationClinical trials—Industry payments4Janssen Biotech, Inc.Clinical trials—Industry payments4Lilly USA, LLCClinical trials—Industry payments4Aurinia Pharma U.S., Inc.Clinical trials—Industry payments2Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments2Genentech USA, Inc.Clinical trials—Industry payments2Kiniksa Pharmaceuticals International, plcClinical trials—Industry payments2Actelion Pharmaceuticals US, Inc.Clinical trials—Industry payments1Alexion Pharmaceuticals, Inc.Clinical trials—Industry payments1Alvogen IncClinical trials—Industry payments1Antares Pharma, Inc.Clinical trials—Industry payments1Biocon Biologics IncClinical trials—Industry payments1Cardinal Health 110 LLCClinical trials—Industry payments1Celltrion USA Inc.Clinical trials—Industry payments1DePuy Synthes Sales Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
18publications

Distinct works indexed by OpenAlex, matched via ORCID.

435citations

Total citations across indexed works.

9h-index

Hirsch index (OpenAlex). i10-index 7.

Clinical & industry

trials, payments and federal funding
37companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Industry payments

Updated 27 Oct 2026

37 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    65.4%
    Interleukin-6 Receptor Antagonist35.2%
    Tocilizumab100%
    Part B, office-administered≥25 patients
    TNF inhibitor19.5%
    Golimumab73%Infliximab27%Enbrel Sureclick0%Humira(Cf)0%
    Part D + Part B<11 patients

    + 5 more classes in this area

  • Musculoskeletal

    31%
    Other drugs affecting bone structure and mineralization23.1%
    Romosozumab-aqqg100%
    Part B, office-administered≥31 patients
    RANK Ligand Inhibitor7.5%
    Denosumab100%
    Part B, office-administered≥89 patients

    + 4 more classes in this area

  • Dermatology

    3%
    Corticosteroid3%
    Methylprednisolone acetate84%Methylprednisolone sodium succinate15%Methylprednisolone1%
    Part D + Part B≥28 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Network

Updated 27 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Kristine A. Kuhn9Andrew Stahly6Blair P. Fennimore4Irbaz Bin Riaz4Jaren R. Trost4Frank I. Scott4Jawad Bilal4Mark E. Gerich4Sandipan Bhattacharjee3Ana Brar3Brendan E. Allen3Sean P. Colgan3Brandon J. Trent3Brenda J. Seymour3Widian K. Jubair3Chian Kent Kwoh2Emilie H. Regner2Meagan E. Chriswell2Drew J.B. Kurtzman2Robert M. Anthony2Sabrina Fechtner2Sunny Lyn Sneed2Charles E. Robertson2Cara C. Wilson2Daniel N. Frank2Erica E. Alexeev2Sucai Liu2Stephanie M. Dillon2Alexander S. Dowdell2Alfredo Ornelas2Jimmy Tangchittsumran2Jennifer M. Kofonow2Alison E. Freeman2Qiong Zhou1Julie A. Reisz1Nikita V. Pozdeyev1Abdullah A. Alhifany1Warda Faridi1Karl B. Kern1Erin L. Ashbeck1

Online presence

Updated 27 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/adam-berlinberg-md

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗

Mentions by others

where others cite or feature them
  • Other

    loop.frontiersin.org/people/1039685

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →loop.frontiersin.org ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Awards & honors

honors on the public record
  • verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →events.arthritis.org ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”